Detalhe da pesquisa
1.
Enter Sofosbuvir: The Path to Curing HCV.
Cell
; 167(1): 25-29, 2016 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634323
2.
SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir.
PLoS Biol
; 20(11): e3001845, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327326
3.
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system.
Hepatology
; 78(2): 621-636, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999539
4.
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.
Hepatology
; 78(6): 1882-1895, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334496
5.
Health-related quality of life in patients aged 6-18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir.
Liver Int
; 44(1): 93-102, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735963
6.
Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta-analysis.
Liver Int
; 44(3): 663-681, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293756
7.
Using HCV-viremic organs for lung transplantation does not confer higher rejection rates compared to HCV-negative organs.
Clin Transplant
; 38(2): e15260, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369851
8.
Serum MicroRNA profiles in chronic hepatitis C Egyptian patients before and after combined sofosbuvir and daclatasvir treatment.
BMC Infect Dis
; 24(1): 67, 2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195397
9.
ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings.
J Pediatr Gastroenterol Nutr
; 78(4): 957-972, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369891
10.
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
Dig Dis Sci
; 69(5): 1551-1561, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38580885
11.
Utilising organs from hepatitis C virus PCR-positive donors in Western Australia.
Intern Med J
; 54(4): 678-681, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450913
12.
Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
Proc Natl Acad Sci U S A
; 118(14)2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811141
13.
Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus.
J Infect Dis
; 228(3): 311-320, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722133
14.
Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review.
Clin Infect Dis
; 77(Suppl 3): S238-S244, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579203
15.
Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment.
Clin Infect Dis
; 76(11): 1959-1968, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694361
16.
Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus.
Antimicrob Agents Chemother
; 67(7): e0039423, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37367486
17.
The pre-conception maternal exposure to Sofosbuvir affects the mitochondrial biogenesis in prenatal fetal tissues: Experimental study on rats.
Mol Med
; 29(1): 71, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280507
18.
Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases.
Am J Kidney Dis
; 82(3): 368-372, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740039
19.
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
J Viral Hepat
; 30(4): 335-344, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601668
20.
Early post-liver transplant use of direct-acting antivirals in naive and NS5A inhibitor-experienced HCV patients.
J Viral Hepat
; 30(3): 201-208, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478502